Company: AVCRF
Filing Date: 2025-06-16
Form Type: 20-F
Source: 0001641172-25-015266
Chunk: 47

Company: Avricore Health Inc.
Filing Date: 2025-06-16
Form: 20-F
Item: Item 10
Chunk 47
---
 retain future earnings for use in its operations and the expansion of its
business.

Notwithstanding
the aforementioned: the Company is unaware of any dividend restrictions; has no specific procedure for the setting of the date of dividend
entitlement; but might expect to set a record date for stock ownership to determine entitlement; has no specific procedures for non-resident
holders to claim dividends, but might expect to mail their dividends in the same manner as resident holders. The Company has not nominated
any financial institutions to be the potential paying agents for dividends in the United States.

10. G.
Statement by Experts

The
Company’s auditor for its consolidated financial statements was Manning Elliot for the years ended December 31, 2024, 2023 &
2022. Their audit reports for the years ended December 31, 2024, 2023, and 2022 are included with the related consolidated financial
statements in this Annual Report.

10. H.
Document on Display

- 
No Disclosure Necessary -

10. J.
Annual Report to Security Holders.

- 
Not applicable -

ITEM
11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK